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Current theories on nitric oxide and sepsis hypothesizethat selective inhibition of guanylate cyclase may bebeneficial in septic shock.1 We present a case of re-fractory hypotension in a pediatric patient with native
mitral valve endocarditis with cerebral complications in whom
methylene blue was less effective than previously described.2,3
Clinical Summary
A 10-year-old girl, weighing 32 kg, with no medical history was
transferred from a regional center with Staphylococcal aureus native
mitral valve endocarditis complicated by cerebral infarction and hem-
orrhage in both frontal lobes, the right thalamus, and possibly the left
caudate nucleus and thalamus. She deteriorated day 2 of admission with
chorda rupture, and an emergency mitral valve operation was indicated.
Standard anesthesia was administered. Preanesthesia inotropes
were dopamine 10 g · kg1 · min1 and epinephrine 0.5 g ·
kg1 · min1. A bolus dose of 2 mg/kg of methylene blue was
given. On commencement of cardiopulmonary bypass, a further 2
mg/kg and an infusion of 1 mg · kg1 · h1 of methylene blue was
commenced. An abscess around the mitral valve annulus was resected
and replaced with a porcine valve. The dilated left atrium and ven-
tricle were reinforced with a bovine pericardial patch.
During bypass, mean arterial pressure was maintained between 30
and 40 mm Hg. Cerebral oximetry ranged from 76% to 93% preby-
pass during methylene blue infusion and from 66% to 82% during
bypass. Surprisingly, methylene blue did not seem to affect oximetry
readings. The CPB time was 133 minutes, and the aortic crossclamp
time was 115 minutes. Weaning from bypass required epinephrine
0.05 to 0.1 g · kg1 · min1, norepinephrine 0.1 g · kg1 ·
min1, vasopressin 0.0001 to 0.0003 g · kg1 · min1, milrinone
0.33 g · kg1 · min1, and methylene blue infusion at 1 mg ·
kg1 · h1 to achieve a systolic arterial pressure of 70 to 80 mm Hg
and diastolic pressure range of 30 to 50 mm Hg.
The patient was transferred to the critical care unit and extu-
bated 6 days later. The methylene blue infusion was ceased on
arrival to the unit. Epinephrine and norepinephrine were ceased the
day after surgery, vasopressin was ceased on postoperative day 2,
and milrinone was ceased on day 8.
Discussion
Septic shock is characterized by arterial hypotension associated
with peripheral vasodilation and the early development of myo-
cardial depression. Nitric oxide has been implicated in these
derangements.2,4 Exposure to endotoxin and cytokines can trigger
a de novo synthesis of the inducible, calcium-dependent isoform of
nitric oxide synthase. Methylene blue inhibits this process by
decreasing intracellular cyclic guanosine monophosphate concen-
trations through guanylate cyclase inhibition, thus blocking its
vasodilator properties.1 Methylene blue increases arterial pressure,
systemic vascular resistance, and left ventricular stroke work but
does not increase cardiac output, oxygen delivery, or oxygen
consumption.4 The release of nitric oxide may be beneficial by
increasing blood flow to ischemic areas, scavenging oxygen free
radicals, and exerting microbiocidal properties.2
Conclusion
A literature review revealed sporadic case reports and 1 prospec-
tive clinical trial in adults using methylene blue to treat the
refractory hypotension in septic shock. A retrospective review
estimated a mortality risk of 66.3% in 1 series for adult patients
with infective endocarditis who had experienced cerebral infarc-
tion within 24 hours preceding cardiac surgery.5 We present a
pediatric case in which refractory hypotension from infective en-
docarditis was treated with methylene blue. The obvious clinical
improvement using methylene blue in a previously published case
report was not evident in this case, but her postoperative course
was relatively benign.2,3 Improvement of blood pressure does not
necessarily correlate with improved tissue perfusion in the patient
with sepsis, and we suggest this case report as further justification
for larger scientifically controlled trials investigating methylene
blue as an agent for refractory hypotension.
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